Biological Therapy Analysis & Statistics, March 2014 (p6)

Talk to Amrita

+1 718 303 2019

Search inside this page

All regions

You might be interested in: stem cell, cell therapy, tissue engineering, more »

151-180 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Analytical Tool - Cancer Immunotherapy

Analytical Tool - Cancer Immunotherapy

  • $ 8 175
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...

  • Industries : Biological Therapy
Analytical Tool - Cancer Therapeutic Antibodies

Analytical Tool - Cancer Therapeutic Antibodies

  • $ 5 924
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. ...

  • Industries : Biological Therapy
Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024

Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024

  • $ 2 985
  • Industry report
  • March 2014
  • by Visiongain

Report Details Stem cell developers and producers - discover companies' R&D and revenue prospects Who are the top stem cell developers and producers? And what are their sales potentials? Visiongain's new ...

  • Industries : Biological Therapy
  • Countries : World, United States, Israel
MannKind Corporation (MNKD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MannKind Corporation (MNKD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

Summary MannKind Corporation (MannKind) is a bio-pharmaceutical company. It discovers, develops and commercializes therapeutic products to treat diseases such as diabetes and cancer. The company's product ...

  • Industries : Biological Therapy
  • Countries : United States
Cell Therapy Deals and Alliances of 2013

Cell Therapy Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Cell Therapy Deals ...

  • Industries : Biological Therapy
Global Circulating Tumor Cells and Cancer Stem Cells Technologies Industry

Global Circulating Tumor Cells and Cancer Stem Cells Technologies Industry

  • $ 4 950
  • Industry report
  • March 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Circulating Tumor Cells and Cancer Stem Cells Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe, Canada, Japan, France, Germany, Italy, Spain, North America, United Kingdom, Russian Federation
Regenerative medicine and Stem cells Partnering Terms and Agreements

Regenerative medicine and Stem cells Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • March 2014
  • by Currentpartnering

The Regenerative Medicine and Stem Cells Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the Regenerative medicine and Stem cells partnering deals ...

  • Industries : Biological Therapy
International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company. The company develops therapeutics to treat diseases of the eye, the nervous system and the liver. ISCC's products include ...

  • Industries : Biological Therapy
  • Countries : India, United States
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: MEDINET Co., Ltd. (2370)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: MEDINET Co., Ltd. (2370)

  • $ 250
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
RNL BIO Co., Ltd. (003190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RNL BIO Co., Ltd. (003190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary RNL BIO Co., Ltd. (RNL BIO) is a biotechnology company, based in Republic of Korea. The company develops, manufactures and markets stem cell therapy products. It offers products and services in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Shenzhen Beike Biotechnology Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Shenzhen Beike Biotechnology Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Shenzhen Beike Biotechnology Co., Ltd. (Beike) is a privately held biotechnology company. The company develops and commercializes adult stem cell therapies. Its service network includes stem cell ...

  • Industries : Biological Therapy
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020

Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020

  • $ 4 515
  • Industry report
  • January 2014
  • by Allied Market Research

Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective ...

  • Industries : Biological Therapy
  • Countries : World
Stemgent, Inc. SWOT Analysis, Strategy, Revenues and Profits

Stemgent, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
MacroGenics, Inc. (MGNX) - Financial and Strategic SWOT Analysis Review

MacroGenics, Inc. (MGNX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

MacroGenics, Inc. (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biological Therapy
Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biological Therapy
  • Countries : France
Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

  • $ 4 650
  • Industry report
  • January 2014
  • by MarketsandMarkets

Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care ...

  • Industries : Biological Therapy
  • Countries : World
Global Mesenchymal Stem Cells Industry

Global Mesenchymal Stem Cells Industry

  • $ 4 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Mesenchymal Stem Cells (MSCs) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest ...

  • Industries : Biological Therapy
Global Neural Control Trends Industry

Global Neural Control Trends Industry

  • $ 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

The report outlines the creation of 'cyborg', a partially machine (robot) and partially human organism represents an artificial conversion of a human to a machine, through an appropriate computer-human ...

  • Industries : Biological Therapy
  • Countries : World
Global Cancer Stem Cell Trends Industry

Global Cancer Stem Cell Trends Industry

  • $ 1 450
  • Industry report
  • January 2014
  • by Global Industry Analysts

The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of the market are the rising affliction of diseases such as cance ...

  • Industries : Biological Therapy
  • Countries : United States
Global Single Cell Omics Trends Industry

Global Single Cell Omics Trends Industry

  • $ 950
  • Industry report
  • January 2014
  • by Global Industry Analysts

Single Cell Omics, a cutting edge technology, mainly integrates advanced technology with biology for a variety of single cell applications. The technology helps to study single cells at a much deeper level ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013

Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • December 2013
  • by Global Markets Direct

Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013” provides ...

  • Industries : Biological Therapy
  • Countries : World
Life Technologies Corporation - Strategy and SWOT Report

Life Technologies Corporation - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2013
  • by MarketLine

Life Technologies Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service ...

  • Industries : Biological Therapy
  • Countries : United States
John Daniel Holdings Limited (JDH) - Financial and Strategic SWOT Analysis Review

John Daniel Holdings Limited (JDH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary John Daniel Holdings Limited (JDHL) is a South African venture capital holding company. The company invests in companies, which are niche and strategic in nature in the healthcare, biotechnology ...

  • Industries : Biological Therapy
  • Countries : South Africa
Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis Review

Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Stem Cell Sciences Plc provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased ...

  • Industries : Biological Therapy
Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

  • $ 645
  • Industry report
  • November 2013
  • by Firstword Pharma

Scope Roche's efforts to enhance its dominance of the haematological cancer market received notable momentum last week when the company gained FDA approval for Gazyva as a first-line treatment for chronic ...

  • Industries : Biological Therapy
  • Countries : United States
Bone Regeneration - Pipeline Review, H2 2013

Bone Regeneration - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Bone Regeneration - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World
Competitor Analysis: CD19-Targeted Therapeutics

Competitor Analysis: CD19-Targeted Therapeutics

  • $ 264
  • Industry report
  • October 2013
  • by La Merie Publishing

Renewed interest in CD19 as target for antibody and T-cell Therapeutics The human CD19 antigen is a 95 kd transmembrane glycoprotein. It is specifically expressed in normal and neoplastic B cells, ...

  • Industries : Biological Therapy
Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017

Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017

  • $ 3 450
  • Industry report
  • October 2013
  • by BioInformant Worldwide, L.L.C.

EXECUTIVE SUMMARY Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Categorized by ...

  • Industries : Biological Therapy
  • Countries : United States
RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • $ 6 650
  • Industry report
  • October 2013
  • by BCC Research

STUDY GOALS AND OBJECTIVES This BCC Research report, RNAi: Technologies and Global Markets, provides an overview of the current state of the RNA interference (RNAi) market, focusing specifically on RNAi ...

  • Industries : Biological Therapy
  • Countries : World
Global MicroRNA Market 2012-2016

Global MicroRNA Market 2012-2016

  • $ 2 500
  • Industry report
  • September 2013
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA ...

  • Industries : Biological Therapy
  • Countries : World

36 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

StemCells Inc.

United States

Bioheart Inc.

United States

Geron Corp.

United States

Osiris Therapeutics Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.